Phio Pharmaceuticals Corp <PHIO.OQ> expected to post a loss of $1.23 a share - Earnings Preview
Phio Pharmaceuticals Corp PHIO.OQ PHIO.O is expected to report resultson March 31 (estimated) for the period ending December 31 2024
LSEG's mean analyst estimate for Phio Pharmaceuticals Corp is for a loss of $1.23 per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Phio Pharmaceuticals Corp is $4.00, above its last closing price of $1.31.
This summary was machine generated March 28 at 20:58 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recommended Articles











